Global Sacubitril-Valsartan Sodium API Market Growth 2024-2030

Global Sacubitril-Valsartan Sodium API Market Growth 2024-2030

Sacubitril-Valsartan API is chemical raw material of Sacubitril/valsartan sodium drugs. Sacubitril/valsartan is a combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker, indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.

The global Sacubitril-Valsartan Sodium API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Sacubitril-Valsartan Sodium API Industry Forecast” looks at past sales and reviews total world Sacubitril-Valsartan Sodium API sales in 2023, providing a comprehensive analysis by region and market sector of projected Sacubitril-Valsartan Sodium API sales for 2024 through 2030. With Sacubitril-Valsartan Sodium API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sacubitril-Valsartan Sodium API industry.

This Insight Report provides a comprehensive analysis of the global Sacubitril-Valsartan Sodium API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sacubitril-Valsartan Sodium API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sacubitril-Valsartan Sodium API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sacubitril-Valsartan Sodium API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sacubitril-Valsartan Sodium API.

United States market for Sacubitril-Valsartan Sodium API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Sacubitril-Valsartan Sodium API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Sacubitril-Valsartan Sodium API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Sacubitril-Valsartan Sodium API players cover Dr. Reddy's Laboratories, Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Sichuan Ren An Pharmaceutical, Jiangxi Longlai Biology Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Sacubitril-Valsartan Sodium API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Purity <99%
Purity ≥99%

Segmentation by Application:
50mg Sacubitril-Valsartan Sodium Tablet
100mg Sacubitril-Valsartan Sodium Tablet
200mg Sacubitril-Valsartan Sodium Tablet

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Dr. Reddy's Laboratories
Zhuhai Rundu Pharmaceutical
Ningbo Menovo Pharmaceutical
Sichuan Ren An Pharmaceutical
Jiangxi Longlai Biology Pharmaceutical
Sichuan Kelun Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sacubitril-Valsartan Sodium API market?

What factors are driving Sacubitril-Valsartan Sodium API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sacubitril-Valsartan Sodium API market opportunities vary by end market size?

How does Sacubitril-Valsartan Sodium API break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.